The oral tyrosine kinase inhibitors lapatinib and sunitinib: new opportunities for the treatment of brain metastases from breast cancer?

被引：2
|
作者：
Addeo, Raffaele [1 ]
Caraglia, Michele [2 ]
机构：
[1] S Giovanni di Dio Hosp, Oncol Unit, ASL Napoli 2, I-80027 Naples, Italy
[2] Univ Naples 2, Dept Biochem & Biophys, I-80138 Naples, Italy
来源：
EXPERT REVIEW OF ANTICANCER THERAPY | 2011年 / 11卷 / 02期
关键词：
blood-brain barrier; brain metastasis; breast cancer; chemotherapy; lapatinib; sunitinib; tyrosine kinase inhibitor; whole-brain radiotherapy; NERVOUS-SYSTEM METASTASES; PHASE-II TRIAL; TEMOZOLOMIDE; CARCINOMA; RADIOTHERAPY; CAPECITABINE; BEVACIZUMAB; COMBINATION; THERAPY; DISEASE;
D O I：
10.1586/ERA.10.190
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：139 / 142
页数：4
相关论文
共 50 条
  • [41] EGFR tyrosine kinase inhibitors in the treatment of cancer
    Barker, AJ
    MEDICINAL CHEMISTRY INTO THE MILLENNIUM, 2001, (264): : 140 - 147
  • [42] Protein tyrosine kinase inhibitors in cancer treatment
    Traxler, PM
    EXPERT OPINION ON THERAPEUTIC PATENTS, 1997, 7 (06) : 571 - 588
  • [43] New targets for therapy in breast cancer - Small molecule tyrosine kinase inhibitors
    Lin, NU
    Winer, EP
    BREAST CANCER RESEARCH, 2004, 6 (05) : 204 - 210
  • [44] Mechanistic Modeling of Central Nervous System Pharmacokinetics and Target Engagement of HER2 Tyrosine Kinase Inhibitors to Inform Treatment of Breast Cancer Brain Metastases
    Li, Jing
    Jiang, Jun
    Bao, Xun
    Kumar, Vineet
    Alley, Stephen C.
    Peterson, Scott
    Lee, Anthony J.
    CLINICAL CANCER RESEARCH, 2022, 28 (15) : 3329 - 3341
  • [45] Therapeutic potential of tyrosine kinase inhibitors in breast cancer
    Averbuch, S
    Kcenler, M
    Morris, C
    Wakeling, A
    CANCER INVESTIGATION, 2003, 21 (05) : 782 - 791
  • [46] Overview of tyrosine kinase inhibitors in clinical breast cancer
    Agrawal, A
    Gutteridge, E
    Gee, JMW
    Nicholson, RI
    Robertson, JFR
    ENDOCRINE-RELATED CANCER, 2005, 12 : S135 - S144
  • [47] Antibodies and Tyrosine Kinase Inhibitors in Breast Cancer Therapies
    Bartha, J.
    Jackisc, Christian
    Untch, Michael
    BREAST CARE, 2009, 4 (01) : 46 - 50
  • [48] Lapatinib in the treatment of brain metastases in patients with breast cancer with overexpression or amplification of the HER2 gene
    Duchnowska, Renata
    ONCOLOGY IN CLINICAL PRACTICE, 2011, 7 : D6 - D9
  • [49] Successful treatment of nonsmall cell lung cancer patients with leptomeningeal metastases using whole brain radiotherapy and tyrosine kinase inhibitors
    Sakaguchi, Masakuni
    Maebayashi, Toshiya
    Aizawa, Takuya
    Ishibashi, Naoya
    Saito, Tsutomu
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2020, 16 (04) : 930 - 932
  • [50] The efficacy and safety of Tyrosine kinase inhibitors in HER-2 positive breast cancer with brain metastases: a systematic review and meta analysis
    Yu, Y.
    Zhang, J.
    Huang, K.
    Lin, Y.
    Song, C.
    BREAST, 2021, 56 : S41 - S41
12345